RUBRIC CAPITAL MANAGEMENT LP

Thesis

They focus on deep-value long positions and an alpha short book, complemented by event-driven strategies, credit exposure, and multi-strategy investments. The firm also engages in private equity and venture capital investments across diversified industries in the U.S., particularly targeting companies undergoing significant transitions like restructurings or capital events. Rubric is known for activist stances, as seen in their engagement with Mereo BioPharma. They have launched a new concentrated fund, the Rubric Long Term Opportunities Onshore Fund and its offshore equivalent, expected to hold longer-duration investments in equities and credit, initially funded with at least $150 million. As of March 1, 2026, AUM was reported at $9.6 billion, with private fund gross asset value at $8.8 billion across three private funds (one hedge fund, two private equity funds). Other reports indicate AUM ranging from $7.1 billion to over $10.9 billion as of mid-2026. The firm manages discretionary assets totaling $4.12 billion for six clients as of March 2024. Their primary geographic scope is the United States. While specific venture capital stage preferences are not detailed, their focus on companies in transition suggests an interest in mature companies or special situations. Their hedge fund activities target public equities, and their private equity arm engages in venture capital investments.

Related lists

• Seed-stage Climate investors
• Seed-stage Fintech investors
• Seed-stage Healthcare investors